Document is current

Article History

Received: 9 February 2023

Accepted: 21 August 2023

First Online: 14 September 2023

Declarations

:

: Dr. Dusetzina is a member of the Institute for Clinical and Economic Review (ICER) Midwest Comparative Effectiveness Public Advisory Council and served on the National Academy of Sciences, Engineering, and Medicine Committee “Ensuring Patient Access to Affordable Drug Therapies.” She serves on the Medicare Payment Advisory Commission. The views expressed in this article are the author’s own and do not reflect the view of the Commission. Dr. Mattingly reports grant support from the U.S. Food and Drug Administration, National Institute on Minority Health and Health Disparities, and PhRMA Foundation and consulting fees from the Arnold Foundation and PhRMA unrelated to this work. Dr. Everson is employed by the Data Analysis Branch, Office of the National Coordinator for Health Information Technology, Department of Health and Human Services. The opinions expressed in this article are the author’s own and do not reflect the view of the Office of the National Coordinator for Health Information Technology, the National Institutes of Health or the National Cancer Institute, the Department of Health and Human Services, or the United States Government.

Free to read: This content has been made available to all.